Cargando…
Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes
BACKGROUND: In severely obese type 2 diabetes patients, gastric bypass surgery (GB) reduces body mass index (BMI) and hemoglobin A1c (HbA1c) and allows reduced doses of insulin and other medications. Data regarding the effects of GB on severely obese patients with type 1 diabetes are limited. METHOD...
Autores principales: | Middelbeek, Roeland J. W., James-Todd, Tamarra, Patti, Mary-Elizabeth, Brown, Florence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122809/ https://www.ncbi.nlm.nih.gov/pubmed/24668543 http://dx.doi.org/10.1007/s11695-014-1228-8 |
Ejemplares similares
-
Gastric Bypass Surgery in Severely Obese Women With Type 1 Diabetes: Anthropometric and Cardiometabolic Effects at 1 and 5 Years Postsurgery
por: Middelbeek, Roeland J.W., et al.
Publicado: (2015) -
Roux-en-Y Gastric Bypass as Conversion Procedure of Failed Gastric Banding: Short-Term Outcomes of 1295 Patients in One Single Center
por: Handojo, Karen, et al.
Publicado: (2023) -
Comment on Brethauer et al. Bariatric Surgery Improves the Metabolic Profile of Morbidly Obese Patients With Type 1 Diabetes. Diabetes Care 2014;37:e51–e52
por: Middelbeek, Roeland J.W., et al.
Publicado: (2014) -
Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity
por: O’Keefe, Stephen J D, et al.
Publicado: (2017) -
How Sustained is Roux-en-Y Gastric Bypass Long-term Efficacy?: Roux-en-Y Gastric Bypass efficacy
por: Guimarães, Marta, et al.
Publicado: (2021)